EUVIMEDEUVIMED entdecken
Crossref

Engineered multivalent VCAM1–Fc decoys remodel ECM mechanosensing to suppress H3K18la–driven epigenetic programs and stemness in recurrent glioblastoma

Yuhang Wang, Alleyar Ali, Junhao Zhu, Yuanming Geng, Chiyuan Ma

Cancer Letters · 2026-10 · 657 · 218698

DOI: 10.1016/j.canlet.2026.218698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026-10. Verfasst von Yuhang Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Glioblastoma, Vascular Cell Adhesion Molecule-1, Neoplastic Stem Cells, Extracellular Matrix. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Jiangsu Province Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recurrent glioblastoma (rGBM) exhibits aggressive progression and therapeutic resistance. However, how mechanical cues within the tumor microenvironment contribute to stemness and chemoresistance through mechanotransductive and epigenetic regulation remains incompletely understood. GBM tissues and derived cell models were systematically characterized to examine how defined matrix mechanical conditions are associated with stemness and chemoresistance. Multivalent VCAM1-Fc decoys were engineered to modulate ITGA4-associated mechanosensing, and mechanistic pathways connecting metabolism to mechanotransduction were interrogated using targeted perturbations. rGBM tissues exhibited elevated stiffness and extracellular matrix (ECM) remodeling, which were associated with enhanced stemness and temozolomide resistance alongside increased H3K18 histone lactylation. Stiffness-associated temozolomide (TMZ) resistance manifested as a pre-activated resistance state prior to TMZ exposure and a shielding effect under high-stiffness conditions that further attenuated TMZ efficacy. ITGA4 was identified as a mechanosensing-associated node, and engineered multivalent VCAM1-Fc decoys mediated valency-dependent, reversible competitive inhibition at cell-surface ITGA4, attenuating mechanosensing-associated stemness and chemoresistance without inducing non-specific cytotoxicity. ECM stiffening is linked to stemness maintenance and temozolomide resistance in recurrent GBM through H3K18la-associated epigenetic regulation, while ITGA4/YAP-related mechanosensing provides a membrane-proximal axis that can be attenuated by multivalent VCAM1-Fc. Multivalent VCAM1-Fc may therefore reduce stiffness-associated malignant phenotypes by limiting ITGA4-dependent mechanotransduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaVascular Cell Adhesion Molecule-1Neoplastic Stem CellsExtracellular MatrixMechanotransduction, CellularHistonesBrain NeoplasmsHumansTemozolomideEpigenesis, GeneticDrug Resistance, NeoplasmCell Line, TumorTumor MicroenvironmentAntineoplastic Agents, AlkylatingAnimalsNeoplasm Recurrence, Local

Stichwörter der Autor:innen

ChemoresistanceECM stiffness sensingRecurrent glioblastomaStemnessVCAM1–Fc decoys

Substanzen

Vascular Cell Adhesion Molecule-1TemozolomideHistonesAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; Department of Neurosurgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Elect…

Förderung

  • Jiangsu Province Department of Science and Technology

Zitieren

APA

Wang, Y., Ali, A., Zhu, J., Geng, Y., & Ma, C. (2026). Engineered multivalent VCAM1–Fc decoys remodel ECM mechanosensing to suppress H3K18la–driven epigenetic programs and stemness in recurrent glioblastoma. Cancer Letters, 657, 218698. https://doi.org/10.1016/j.canlet.2026.218698

Vancouver

Wang Y, Ali A, Zhu J, Geng Y, Ma C. Engineered multivalent VCAM1–Fc decoys remodel ECM mechanosensing to suppress H3K18la–driven epigenetic programs and stemness in recurrent glioblastoma. Cancer Letters. 2026;657:218698. doi:10.1016/j.canlet.2026.218698

BibTeX
@article{Wang2026,
  author = {Wang, Yuhang and Ali, Alleyar and Zhu, Junhao and Geng, Yuanming and Ma, Chiyuan},
  title = {Engineered multivalent VCAM1–Fc decoys remodel ECM mechanosensing to suppress H3K18la–driven epigenetic programs and stemness in recurrent glioblastoma},
  journal = {Cancer Letters},
  year = {2026},
  volume = {657},
  pages = {218698},
  doi = {10.1016/j.canlet.2026.218698}
}
Kostenlos starten →